SIWA Therapeutics' Unattributed Round

SIWA Therapeutics raised a round of funding on May 22, 2017.

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells. The company's current therapeutic focus is on ce…

Articles about SIWA Therapeutics' Unattributed Round: